《Endocrine Metabolic & Immune Disorders-drug Targets》是一本由BENTHAM SCIENCE PUBL LTD出版商出版的专业医学期刊，该刊创刊于2001年，刊期6 issues/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：内分泌学与代谢 4区；免疫学 4区；药学 4区；在JCR（Journal Citation Reports）分区等级为Q4。该刊发文范围涵盖内分泌学与代谢等领域，旨在及时、准确、全面地报道国内外内分泌学与代谢工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为2.387，

Endocrine Metabolic & Immune Disorders-drug Targets英文介绍

Aims & Scope

This journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.

Endocrine Metabolic & Immune Disorders-drug Targets中科院分区

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	4区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢 IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学	4区 4区 4区	否	否

Endocrine Metabolic & Immune Disorders-drug Targets期刊近9年JCR分区变化趋势

Endocrine Metabolic & Immune Disorders-drug TargetsJCR分区(JCR2021-2022年分区)

JCR分区等级	JCR所属学科	分区	影响因子
Q4	ENDOCRINOLOGY & METABOLISM	Q4	2.387
	PHARMACOLOGY & PHARMACY	Q4
	IMMUNOLOGY	Q4

Endocrine Metabolic & Immune Disorders-drug Targets期刊近7年影响因子变化趋势

Endocrine Metabolic & Immune Disorders-drug Targets期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore	SJR	SNIP	学科类别	分区	排名	百分位
3.80	0.490	0.699	大类：Medicine 小类：Endocrinology, Diabetes and Metabolism	Q3	125 / 227	45%
3.80	0.490	0.699	大类：Medicine 小类：Immunology and Allergy	Q3	125 / 200	37%

Endocrine Metabolic & Immune Disorders-drug Targets期刊近7年自引率变化趋势

上周TOP10